Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 6Lymphoid 5Sarcoma 2Classical hematology 2Plasma cell 1Dermatologic 1

Conditions

Multiple Myeloma 14Lymphoma, Non-Hodgkin 10Myelodysplastic Syndromes 9Leukemia, Myeloid, Acute 8Leukemia 8Hodgkin Disease 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Neoplasms, Plasma Cell 6Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Lymphoma 5Burkitt Lymphoma 5Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Recurrence 3Leukemia, Myeloid, Accelerated Phase 3Hematologic Neoplasms 3Blast Crisis 3Testicular Neoplasms 2Primary Myelofibrosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Promyelocytic, Acute 2Leukemia, Prolymphocytic 2

Interventions

fludarabine phosphate 26Cyclophosphamide 25Peripheral Blood Stem Cell Transplantation 24Mycophenolic Acid 20Tacrolimus 17Cyclosporine 17Busulfan 16Antilymphocyte Serum 13Filgrastim 12Methotrexate 11Radiotherapy 9Whole-Body Irradiation 8Melphalan 8Etoposide 8Sirolimus 7Methylprednisolone 7Cord Blood Stem Cell Transplantation 7Flow Cytometry 6Cyclosporins 6Psychiatric Rehabilitation 5Polymerase Chain Reaction 4Alemtuzumab 4Rituximab 3Immunologic Techniques 3Immunoenzyme Techniques 3Early Intervention, Educational 3Doxorubicin 3Cytarabine 3thymoglobulin 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × Thiotepa × Plasma cell × Clear all
NCT02861417 2026-02-17

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
204 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡